ACLARUBICIN HYDROCHLORIDE
- CAS NO.:75443-99-1
- Empirical Formula: C42H54ClNO15
- Molecular Weight: 848.33
- MDL number: MFCD00133024
- EINECS: 278-209-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-07-02 08:55:03
What is ACLARUBICIN HYDROCHLORIDE?
Definition
ChEBI: Aclarubicin hydrochloride is an anthracycline.
Biological Activity
Aclacinomycin A hydrochloride (Aclarubicin hydrochloride) is a fluorescent molecule and the first non-peptidic inhibitor discovered to have discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. It is also a dual inhibitor of topoisomerase I and II (topoisomerase I and II). It is an effective anthracycline chemotherapeutic agent for blood cancer and solid tumor related research.
in vitro
Aclacinomycin A could efficiently enter living cells and emit fluorescence in situ . Aclacinomycin A (10 μM for 15 min) is sufficient for clear detection of fluorescence in most of the cultured cells. Aclacinomycin A treatment (10 μM Acla for 15 min) results in approximately 20% dead (or nearly dead) cells.
Aclacinomycin A (Aclarubicin) effectively induces incorporation of exon 7 into SMN2 transcripts from the endogenous gene in type I SMA fibroblasts as well as into transcripts from a SMN2 minigene in the motor neuron cell line NSC34 .
in vivo
Aclarubicin hydrochloride(Aclacinomycin A) is very well absorbed in mice, rats, and dogs after its oral administration. The oral LD 50 (76.5 mg/kg) is about twice the iv LD 50 (35.6 mg/kg) in mice [4 .
Aclacinomycin A ( 0.75-6 mg/kg, ip daily) dose-dependently exhibits tumor growth in mice-based Leukemia P-388 model [4 .
| Animal Model: | DBA/2, CDF 1 ( BALB/c×DBA/2) mice with Leukemia P-388 [4 . | tr>
| Dosage: | 0.75 mg/kg, 1.5 mg/kg, 3 mg/kg, 6 mg/kg. | td>
| Administration: | Intraperit oneal administration daily for 10 days starting 3 hr after transplantation. |
| Result: | Inhibited tumor growth. |
Properties of ACLARUBICIN HYDROCHLORIDE
| Melting point: | 151-153℃ |
| Boiling point: | 898℃ |
| Flash point: | >110°(230°F) |
| storage temp. | 2-8°C |
| solubility | Soluble in DMSO or DMF at 25mg/ml |
| form | Solid |
| color | Light yellow to yellow |
Safety information for ACLARUBICIN HYDROCHLORIDE
| Pictogram(s) |
![]() Skull and Crossbones Acute Toxicity GHS06 |
| GHS Hazard Statements |
H301:Acute toxicity,oral H311:Acute toxicity,dermal H331:Acute toxicity,inhalation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P405:Store locked up. |
Computed Descriptors for ACLARUBICIN HYDROCHLORIDE
New Products
4-Bromo-2-chlorobenzonitrile 1-Chloro-4-Methyl-2-Nitrobenzene 1,3-Diethyl-1,3-Diphenylurea 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile Methyl 2-methylquinoline-6-carboxylate 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile Chlorodehydromethyl testosterone Cisplatin Prednisolone acetate Trenbolone Enanthate Benzethonium Chloride Testosterone acetate 1,3-Di Iodo Benzene Methyl 2-oxo-2,3-dihydrobenzo[d]oxazole-7-carboxylate 3-Hydroxy-4-nitrobromobenzene 4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 2-Ethyl-1,4-diaminobenzene 2-Ethylhexyl 4-aminobenzoate Boc-L-Leucinol Calcium Ascorbate Boc-Tyr-OH tert-butyl 2-oxo-1,4,9-triazaspiro[5.5]undecane-9-carboxylate 1-(1-(tert-butoxycarbonyl)piperidin-4-yl)-1H-pyrazole-4-carboxylic acid (1R,5S)-6,6-dimethylbicyclo[3.1.1]heptan-2-oneRelated products of tetrahydrofuran








You may like
-
2124221-11-8 (4-(methylamino)phenyl)methanesulfonic acid 98%View Details
2124221-11-8 -
Boc-Arg-OH HCl H2O 114622-81-0 98%View Details
114622-81-0 -
2-(2-chloropyrimidin-4-yl)acetic acid 98%View Details
1211581-39-3 -
15761-38-3 Boc-Ala-OH 98%View Details
15761-38-3 -
42074-68-0 98%View Details
42074-68-0 -
20866-46-0 Boc-His(Boc)-OH 98%View Details
20866-46-0 -
31954-27-5 Boc-Gly-OMe 98%View Details
31954-27-5 -
2-(4-(tert-butoxycarbonyl)piperazin-2-yl)acetic acid 98%View Details
183591-72-2

